hexamethylene bisacetamide has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dmitrovsky, E; Miller, WH | 1 |
| Baselga, J; Dmitrovsky, E; Grippo, JF; Kurie, J; Lucas, DA; Maerz, WJ; Masui, H; Miller, WH; Moy, D | 1 |
1 review(s) available for hexamethylene bisacetamide and transforming growth factor alpha
| Article | Year |
|---|---|
Growth factors in human germ cell cancer.
Topics: Acetamides; Cell Differentiation; Fibroblast Growth Factor 4; Fibroblast Growth Factors; Growth Substances; Humans; Neoplasms, Germ Cell and Embryonal; Oncogene Proteins; Proto-Oncogene Proteins; Transforming Growth Factor alpha; Tretinoin | 1991 |
1 other study(ies) available for hexamethylene bisacetamide and transforming growth factor alpha
| Article | Year |
|---|---|
All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.
Topics: Acetamides; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Line; Clone Cells; Drug Resistance; Fibroblast Growth Factor 4; Fibroblast Growth Factors; Gene Expression; Humans; Proto-Oncogene Proteins; Teratocarcinoma; Transforming Growth Factor alpha; Tretinoin; Tumor Cells, Cultured | 1994 |